Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., Baldwin Jr., A. IκB interacts with the nuclear localization sequences of the subunits of NF-κB a mechanism for cytoplasmic retention. Genes Dev. 1992; 6: 1899-1913.
Kumar, J., Bhanu, P., Buchke, S., Kumar, NH., Mallick, D. and Mishra, V. 2021. Screening of potential viral drugs for COVID19 by targeting nuclear factor-Kappa B receptor. (Unpublished)
Cardoso WB, Mendanha SA. Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors. J Mol Struct. 2021 Feb 5;1225:129143. doi: 10.1016/j.molstruc.2020.129143.Zhao et al., 2020
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, Jamie Frankish, Ji-Young Lee, Agnieszka Plociennikowska, Florian Heigwer, Sebastian Joecks, Sandy S. Burkart, David Y. Zander, Mathieu Gendarme, Bachir El Debs, Niels Halama, Uta Merle, Michael Boutros, Marco Binder, Ralf Bartenschlager bioRxiv 2020.07.21.212639; doi: https://doi.org/10.1101/2020.07.21.212639.
Elkhodary, M. (2020). Treatment of COVID-19 by controlling the activity of the nuclear factor-Kappa B. CellBio, 09, 109–121.
Ganchi P.A., Sun S.C., Greene W.C., Ballard D.W. IκB/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell. 1992; 3: 1339-1352.
Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Meyer B, Roesch F, Vallet T, Mac Kain A, Miorin L, Moreno E, Naing ZZC, Zhou Y, Peng S, Shi Y, Zhang Z, Shen W, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Lyu J, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Rakesh R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Huang XP, Liu Y, Wankowicz SA, Bohn M, Safari M, Ugur FS, Koh C, Savar NS, Tran QD, Shengjuler D, Fletcher SJ, O'Neal MC, Cai Y, Chang JCJ, Broadhurst DJ, Klippsten S, Sharp PP, Wenzell NA, Kuzuoglu-Ozturk D, Wang HY, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Stroud RM, Frankel AD, Rosenberg OS, Verba KA, Agard DA, Ott M, Emerman M, Jura N, von Zastrow M, Verdin E, Ashworth A, Schwartz O, d'Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor SN, Fraser JS, Gross JD, Sali A, Roth BL, Ruggero D, Taunton J, Kortemme T, Beltrao P, Vignuzzi M, García-Sastre A, Shokat KM, Shoichet BK, Krogan NJ. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9.
Hariharan, A., Hakeem, A.R., Radhakrishnan, S. et al. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients. Inflammopharmacol 29, 91–100 (2021). https://doi.org/10.1007/s10787-020-00773-9.
Jacobs MD, Harrison SC. Structure of an IkappaBalpha/NF-κB complex. Cell. 1998 Dec 11;95(6):749-58. doi: 10.1016/s0092-8674(00)81698-0. PMID: 9865693.
Jorgensen, W.L.; Tirado-Rives, J., "The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin," J. Am. Chem. Soc., 1988, 110(6), 1657-1666.
Kandasamy M. (2021). NF-κB signalling as a pharmacological target in COVID-19: potential roles for IKKβ inhibitors. Naunyn-Schmiedeberg's archives of pharmacology, 394(3), 561–567. https://doi.org/10.1007/s00210-020-02035-5.
Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S. The ClusPro web server for protein-protein docking. Nat Protoc. 2017 Feb;12(2):255-278. doi: 10.1038/nprot.2016.169. Epub 2017 Jan 12. PMID: 28079879; PMCID: PMC5540229.
Laskowski R A, Jabłońska J, Pravda L, Vařeková R S, Thornton J M (2018). PDBsum: Structural summaries of PDB entries. Prot. Sci., 27, 129-134.
Laskowski R A, Swindells M B (2011). LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model., 51, 2778-2786. PMID: 21919503
Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002 Oct;2(10):725-34. doi: 10.1038/nri910.
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023–. doi: 10.1038/sigtrans.2017.23.
Lokhande KB, Doiphode S, Vyas R, Swamy KV. Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. J Biomol Struct Dyn. 2020 Aug 20:1-12. doi: 10.1080/07391102.2020.1805019. Epub ahead of print. PMID: 32815481; PMCID: PMC7484567.
Mahase E. Covid-19: what treatments are being investigated? BMJ 2020; 368 :m1252 doi:10.1136/bmj.m1252.
Martinez IL, Llinás DT, Romero MB, Salazar LM (2020) High Mutation Rate in SARS-CoV-2: Will It Hit Us the Same Way Forever?. J Infect Dis Epidemiol 6:176. doi.org/10.23937/2474-3658/1510176.
Murugan NA, Kumar S, Jeyakanthan J, Srivastava V. Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach. Sci Rep. 2020 Nov 5;10(1):19125. doi: 10.1038/s41598-020-75762-7.
Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. doi: 10.1101/cshperspect.a000034.
Pablo R. Arantes, Aakash Saha, and Giulia Palermo. Fighting COVID-19 Using Molecular Dynamics Simulations. ACS Central Science 2020 6 (10), 1654-1656.DOI: 10.1021/acscentsci.0c01236.
Rath SL and Kumar K (2020) Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations. Front. Mol. Biosci. 7:583523. doi: 10.3389/fmolb.2020.583523
Selvaraj C, Dinesh DC, Panwar U, Abhirami R, Boura E, Singh SK. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19. J Biomol Struct Dyn. 2020 Jun 22:1-12. doi: 10.1080/07391102.2020.1778535. Epub ahead of print. PMID: 32567979; PMCID: PMC7332868.
Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367. doi: 10.1093/nar/gky473. PMID: 29860391; PMCID: PMC6031066.
Wang Q.; Zhang Y.; Wu L.; Niu S.; Song C.; Zhang Z.; Lu G.; Qiao C.; Hu Y.; Yuen K.-Y.; et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 2020, 181, 894–904.e9. 10.1016/j.cell.2020.03.045.
Zhang et al. 2017; Zhang Q, Lenardo MJ, Baltimore D. 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology. Cell. 2017 Jan 12;168(1-2):37-57. doi: 10.1016/j.cell.2016.12.012.